This article discusses the causes, risk factors, signs, and symptoms of cystic fibrosis, a genetic disorder that affects the lungs and pancreas. It also explores effective treatment procedures for this progressive disease.
Contribute Materials
Your contribution can guide someone’s learning journey. Share your
documents today.
Running head: CYSTIC FIBROSIS CYSTIC FIBROSIS Name of the Student: Name of the University: Author Note:
Secure Best Marks with AI Grader
Need help grading? Try our AI Grader for instant feedback on your assignments.
1 CYSTIC FIBROSIS Cystic fibrosis is one of the progressive as well as genetic disorder that is mainly responsible for creating persistent lung infections. This thereby limits the capability for effective breathing of the individuals over time (Wainwright et al., 2015). It also causes malnutrition and poor growth due to affecting the pancreas causing inflammation. This assignment will mainly show causes, risk factors, signs and symptoms of the disorder along with its treatment procedures. Lungs are the main part of the respiratory system besides the muscles that aid in respiration like the intercostals muscles and diaphragm. They take in oxygen from the atmosphere and pass it to the red blood cells. They gain take carbon dioxide from red blood cells and release it out to atmosphere. When air enters in the respiratory system, it travels down from mouth or that of nose. They are then seen to enter in the trachea or the windpipe thereby reaching to the carina. The windpipe is then seen to split into two forming the main stem bronchus that in turn is seen to lead into the respective lungs (Ooi, Tullis & Durie, 2016). They further branch more into pipe like bronchi that further break into alveoli that ultimately causes the main gas exchange with the capillaries present here. This helps in external respiration. The panaceas is a part of the digestive systemthat mainly comprise of the exocrine tissues that include digestive juices for breakdown of protein, carbohydrate and fatty acids and cholesterol thereby helping in digestion when food enters in duodenum. The endocrine part releases insulin helping in maintaining blood glucose level (Cutting, 2015). Family history is mainly the most important risk factor for the disorder of cystic fibrosis. The disorderiscaused by the mutation ofthe specific type ofgene called thegenecystic fibrosis transmembrane conductance regulator(CFTR). It is an autosomal recessive disorder and when individuals receive one copy of the defected gene from each of the parent. Each of the parents has to be the carrier of at least copy of the gene and when children get one copy each from their parents, the disorder is seen to affect the individuals. Mutation in the gene mainly causes modification of the gene that mainly contributes to the movement of salt in and out of the cells. This is then seen to result in the occurrence of thick and even sticky mucus in the respiratory as well as the reproductive and digestive systems and
2 CYSTIC FIBROSIS causes increase of salt content in the sweat (Stoltz et al., 2015). The mucus in the lungs are seen to block bacteria and other germs and it becomes difficult for the antibiotics and the immune cells to penetrate. This causes issues and poor quality life of the patients. Moreover, although it occurs in all races, whites are more prone to this disorder than the others are. Cystic fibrosis is mainly caused when cells responsible for the production of mucus, digestive juices as well as sweat gets affected. Under normal situation, these cells are seen to produce fluids that are slippery and thin. However, in case of patients with cystic fibrosis, presence of a defective gene results in the secretion of the thick and sticky mucus. Therefore, the fluid that should mainly act as lubricant starts producing mucus that are seen to plug up the tubes, and even the ducts and passageways mainly affecting the lungs and the pancreas. Thickened secretions are also seen to release from the pancreas that is actually responsible for providing of the digestive juices helping in the breakdown of the food. These secretions become responsible for creating blockage in the exocrine movement of the festive enzymes entering in the duodenum (Narayan et al., 2015). This results in the occurrence of irreversible damage in the pancreas resisting in painful inflammation. The mucus in the pancreas prevent the absorption of key nutrients and food that cause malnutrition and poor growth. The mucus can block the bile duct in the liver causing liver diseases. Individuals suffering from the cystic fibrosis are seen to contain high level of alt in their sweat. Besides, they have also several symptoms of the ineffective respiratory system where the individuals may have a persistent cough that can be seen to produce thick mucus. This mucus blocks the air tubes that helps the lungs to carry in or the out of the gases. Wheezing breathlessness and repeated recurrence of lung infections are seen. Exercise intolerance as well as inflammation of the nasal passages or that of the stuffy nose are also associated with the disorder. Issues in the digestive system that are seen to occur is the foul smelling of the greasy tools as well as poor weight gain and even poor growth. Intestinal blockage with that of meconium ileus is seen and individuals suffer from constipation (Shah et al., 2016). When an individual or his or her partner has close relatives who are affected by the disorder, it is advisable for them to undertake important genetic testing before they start family planning. The test is
3 CYSTIC FIBROSIS mainly done in lab with a sample of blood and has the capability of determining the risk whether the individual will have child with the disorder or not. When an individual is already pregnant, they should conduct the test to identify the risk and the professional can conduct additional tests. Researchers are of the opinion that before one takes the test, he should talk with the genetic counselor about the psychological impact that the test results may carry (Farrell et al. 2017). People with this disorder can closely work together medical professionals as well as families for creating of individualized treatment plans. Three important therapies can be shown here that are important. The first one is the airway clearances that helps in the loosening and ultimately help in getting rid of the thick mucus which are seen to be developed in the lungs. This technique is mainly seen to require the help of the friends, family members and even the respiratory therapists. Many of the patients are also seen to use the inflatable vest that is seen to vibrate the chest region at the higher frequency for thinning and loosening the mucus. Another therapy is the inhaled medicines utilization for the opening of the airways or the thinning of the mucus. These medications mainly come in the form of the liquid medications that are made in the form of mist or aerosol. This is then inhaled with the use of the nebulizer. These medications are seen to include the antibiotics that help in fighting the lung infections as well as also include therapies that help in keeping the airways clean. Another therapy is the pancreatic enzyme supplement capsules. This is seen to cause improvement of the vital nutrients and is take with every meal and snacks. Multivitamins are also given (Saiman & Planet, 2016). From the above discussion, it becomes clear that this disorder is the genetic disorder where the family history of both parents being the carrier of the defective gene increases the chances of the disorder. Lung and pancreas are the organs that are affected and this creates issues in breathing as well as digestion. Effective treatment therapies can help the individuals to overcome the symptoms and lead quality lives.
Paraphrase This Document
Need a fresh take? Get an instant paraphrase of this document with our AI Paraphraser
4 CYSTIC FIBROSIS References: Cutting,G.R.(2015).Cysticfibrosisgenetics:frommolecularunderstandingtoclinical application.Nature Reviews Genetics,16(1), 45. Farrell, P. M., White, T. B., Ren, C. L., Hempstead, S. E., Accurso, F., Derichs, N., ... & Sermet- Gaudelus, I. (2017). Diagnosis of cystic fibrosis: consensus guidelines from the Cystic Fibrosis Foundation.The Journal of pediatrics,181, S4-S15. Narayanan, S., Blondeau, W., Zimet, G. D., & Ganser, R. (2015). Translation and Linguistic Validation of the Caregiver Quality of Life Cystic Fibrosis Scale (Cqolcf) and the Multidimensional Scale of Perceived Social Support (Mspss) for use in Germany and the United Kingdom (Uk).Value in Health,18(7), A716. Ooi, C. Y., Tullis, E., & Durie, P. R. (2016). Diagnostic Approach to Diseases Associated with Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations. InCystic Fibrosis(pp. 122- 141). CRC Press. Saiman, L., & Planet, P. J. (2016). Microbiology in Cystic Fibrosis. InCystic Fibrosis(pp. 55-75). CRC Press. Shah, V. S., Meyerholz, D. K., Tang, X. X., Reznikov, L., Alaiwa, M. A., Ernst, S. E., ... & Allen, P. D. (2016).Airwayacidificationinitiateshostdefenseabnormalitiesincysticfibrosis mice.Science,351(6272), 503-507. Stoltz, D. A., Meyerholz, D. K., & Welsh, M. J. (2015). Origins of cystic fibrosis lung disease.New England Journal of Medicine,372(4), 351-362.
5 CYSTIC FIBROSIS Wainwright, C. E., Elborn, J. S., Ramsey, B. W., Marigowda, G., Huang, X., Cipolli, M., ... & Konstan, M. W. (2015). Lumacaftor–ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR.New England Journal of Medicine,373(3), 220-231.